Breaking News

For biotech's ‘godfather,' saving Biogen is his final act; stroke prevention study will test Apple Watch's promise in health

 

Daily Recap

STAT+: For the 'godfather' of biotech, saving Biogen is the final act of a singular career

By Damian Garde

Mike Reddy for STAT

Stelios Papadopoulos, at the summit of a career spanning most of biotech’s recorded history, faces a challenge that will color his legacy.

Read More

STAT+: Fed up with costly, onerous recertification, doctors are turning to an alternative board

By Tara Bannow

Adobe

Fed up with the costly, onerous process of recertification, doctors are increaasingly turning to an alternative board.

Read More

An ambitious stroke prevention study tests the Apple Watch's promise in health

By Mario Aguilar

Adobe

A new study will investigate whether Apple Watches can help minimize unnecessary use of blood thinners in patients with A-fib.

Read More

Opinion: Amazon and One Medical: Minding the data gaps

By Alexander Chaitoff and Khin-Kyemon Aung and Alexander Zheutlin

One Medical

The neighborhoods with One Medical clinics don't look anything like average U.S. neighborhoods. That could be a key data gap for Amazon.

Read More

STAT+: As medical device companies look to snap up Medicare dollars, potential conflicts lurk

By Bob Herman

Adobe

Medical device companies are hoping to persuade CMS to dole out higher payments for several types of products and services.

Read More

Opinion: Restoring trust in public health: There are no shortcuts

By Mark R. Miller and Julia Haskins

Shawn Thew-Pool/Getty Images

To work effectively in public health, leaders must not only tell people what they know, but also what they don't know.

Read More

Monday, August 29, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments